ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 11 Nov 2024
Last Applicant/ Owned by
545 Fifth Avenue, Suite 1400
New York
NY
10017
Serial Number
90430299 filed on 30th Dec 2020
Registration Number
N/A
Correspondent Address
Anna Kurian Shaw
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VYXARIQ
Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90430299
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 761350.00241
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Nov 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 11th Nov 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 23rd Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Mar 2024 | SOU EXTENSION 5 GRANTED |
| 22nd Mar 2024 | SOU EXTENSION 5 FILED |
| 22nd Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 21st Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Sep 2023 | SOU EXTENSION 4 GRANTED |
| 19th Sep 2023 | SOU EXTENSION 4 FILED |
| 19th Sep 2023 | SOU TEAS EXTENSION RECEIVED |